Non-interventional Study of Kyprolis® in Combination With Revlimid® and Dexamethasone or Dexamethasone Alone or in Combination With Darzalex® and Dexamethasone in Multiple Myeloma Patients

Active, not recruitingOBSERVATIONAL
Enrollment

359

Participants

Timeline

Start Date

October 25, 2016

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Multiple Myeloma in Relapse
Interventions
DRUG

Carfilzomib

In accordance with SmPC.

Trial Locations (1)

60389

Centrum für Hämatologie und Onkologie Bethanien, Frankfurt

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

iOMEDICO AG

INDUSTRY

NCT02970747 - Non-interventional Study of Kyprolis® in Combination With Revlimid® and Dexamethasone or Dexamethasone Alone or in Combination With Darzalex® and Dexamethasone in Multiple Myeloma Patients | Biotech Hunter | Biotech Hunter